Nine-year-old Jackson Moore has Angelman syndrome, a condition that delays his development. His mother, Amanda Moore, said ...
UConn School of Medicine Neuroscientist Dr. Eric Levine’s innovative autism research is reprogramming the donated skin or blood cells of patients like Fiona to develop them in the lab into brain cells ...
Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug.
Taysha Gene Therapies, Inc.’s TSHA share price has dipped by 11.15%, which has investors questioning if this is right time to ...
HC Wainwright reissued their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published ...
This story was originally published by the Indiana Capital Chronicle. By Whitney Downard Indiana Capital Chronicle April 2, ...
The rally focused on Senate Bill 2 which would require Medicaid recipients to all users to re-apply for Medicaid coverage ...
20 Minutes on MSN5d
« Un soulagement »… Il y a un an, ce couple a enfin mis un nom sur la maladie génétique de leur fille, le syndrome ReNUComme des milliers de parents dans le monde, Carole Hervé et Damien Delahaie ont appris l’an dernier que leur petite fille de ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback